<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36418784</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1618-7601</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The European journal of health economics : HEPAC : health economics in prevention and care</Title><ISOAbbreviation>Eur J Health Econ</ISOAbbreviation></Journal><ArticleTitle>EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>1399</StartPage><EndPage>1410</EndPage><MedlinePgn>1399-1410</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10198-022-01551-w</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study assessed patient-reported health-related quality of life (HRQoL) using two generic preference-based measures in Chinese patients with spinal and bulbar muscular atrophy (SBMA) and identified demographic and clinical determinants of health utility scores in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study used cross-sectional data of 212 Chinese patients with SBMA who completed both the EQ-5D and SF-6D. Association between response to EQ-5D and SF-6D dimensions was examined using Spearman's correlation coefficient, and the association between the two utility scores was assessed using Pearson's correlation coefficient. The variations in utility scores across patients in different subgroups were compared using one-way ANOVA. Bland-Altman (B-A) plot was used to assess the agreement of utility scores between EQ-5D and SF-6D. A multivariate Tobit regression model was employed to estimate the association between utility scores and the presence of symptoms and chronic conditions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean utility scores for the EQ-5D and SF-6D were 0.54 and 0.56, respectively. The hypothesized correlation between the EQ-5D and SF-6D dimensions ranged from 0.31 to 0.58, and the correlation between their utility scores was 0.64. An acceptable agreement between EQ-5D and SF-6D utility scores was identified by B-A plot. Patients with chronic diseases, misdiagnosis, high financial burden, and several clinical symptoms were highly likely to report a low health utility score.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study is the first to investigate the HRQoL of patients with SBMA worldwide. The estimated health utility scores for EQ-5D and SF-6D can be utilized as baseline data for future cost-utility analyses of SBMA-related interventions.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Richard Huan</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuyang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, 100730, China. shuyangzhang103@nrdrs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Dong</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9784-6472</Identifier><AffiliationInfo><Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, SAR, China. dongdong@cuhk.edu.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, Guangdong, China. dongdong@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016YFC0901500</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2016ZX310174-4</GrantID><Agency>the Center for Rare Diseases Research, Chinese Academy of Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Health Econ</MedlineTA><NlmUniqueID>101134867</NlmUniqueID><ISSNLinking>1618-7598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006305" MajorTopicYN="N">Health Status Indicators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Generic preference-based measures</Keyword><Keyword MajorTopicYN="N">Health utility score</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Spinal and bulbar muscular atrophy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36418784</ArticleId><ArticleId IdType="doi">10.1007/s10198-022-01551-w</ArticleId><ArticleId IdType="pii">10.1007/s10198-022-01551-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rhodes, L.E., Freeman, B.K., Auh, S., et al.: Clinical features of spinal and bulbar muscular atrophy. Brain (London Engl. 1878) 132, 3242&#x2013;3251 (2009)</Citation></Reference><Reference><Citation>Orphanet: Kennedy disease. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=481 . Accessed 26 Nov. 2020</Citation></Reference><Reference><Citation>Breza, M., Koutsis, G.: Kennedy&#x2019;s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J. Neurol. 266, 565&#x2013;573 (2019). https://doi.org/10.1007/s00415-018-8968-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8968-7</ArticleId><ArticleId IdType="pubmed">30006721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume, A., Katsuno, M., Banno, H., et al.: Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain (London Engl. 1878) 135, 2838&#x2013;2848 (2012)</Citation></Reference><Reference><Citation>Atsuta, N., Watanabe, H., Ito, M., et al.: Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain (London Engl. 1878) 129, 1446&#x2013;1455 (2006)</Citation></Reference><Reference><Citation>Brazier, J.: Measuring and Valuing Health Benefits for Economic Evaluation, 2nd edn. Oxford University Press, Oxford (2007)</Citation></Reference><Reference><Citation>Whitehead, S.J., Ali, S.: Health outcomes in economic evaluation: the QALY and utilities. Br. Med. Bull. 96, 5&#x2013;21 (2010). https://doi.org/10.1093/bmb/ldq033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldq033</ArticleId><ArticleId IdType="pubmed">21037243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, Q.-Q., Hou, Y., Chen, Y., et al.: Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L. Health Qual Life Outcomes 19, 181 (2021). https://doi.org/10.1186/s12955-021-01822-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01822-9</ArticleId><ArticleId IdType="pubmed">34284776</ArticleId><ArticleId IdType="pmc">8290546</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossnohere, N.L., Fischer, R., Lloyd, A., et al.: Assessing the appropriateness of the EQ-5D for Duchenne muscular dystrophy: a patient-centered study. Med. Decis. Mak. 41, 209&#x2013;221 (2021). https://doi.org/10.1177/0272989X20978390</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X20978390</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin, R., de Charro, F.: EQ-SD: a measure of health status from the EuroQol Group. Ann. Med. 33, 337&#x2013;343 (2001). https://doi.org/10.3109/07853890109002087</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890109002087</ArticleId><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazier, J.E., Roberts, J.E.: The estimation of a preference-based measure of health from the SF-12. Med. Care 42, 851&#x2013;859 (2004). https://doi.org/10.1097/01.mlr.0000135827.18610.0d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000135827.18610.0d</ArticleId><ArticleId IdType="pubmed">15319610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, H.-M., Patrick, D., Edwards, T., et al.: Validation of the EQ-5D in a general population sample in urban China. Qual. Life Res. 21, 155&#x2013;160 (2012). https://doi.org/10.1007/s11136-011-9915-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9915-6</ArticleId><ArticleId IdType="pubmed">21505881</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, D., Chung, R.Y.N., Chan, R.H.W., et al.: Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China. Orphanet. J. Rare Dis. 15, 1&#x2013;12 (2020). https://doi.org/10.1186/s13023-020-01587-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01587-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz, C.O., Morris, P.E., Richler, J.J.: Effect size estimates: current use, calculations, and interpretation. J. Exp. Psychol. 141, 2&#x2013;18 (2012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0024338</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, R.H., Wong, E.L.Y., Jin, J., et al.: Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas. Eur. J. Heal Econ. (2020). https://doi.org/10.1007/s10198-020-01220-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-020-01220-w</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna (2013). https://www.r-project.org/</Citation></Reference><Reference><Citation>Yang, Z., Busschbach, J., Liu, G., et al.: EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes 16, 210 (2018). https://doi.org/10.1186/s12955-018-1036-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-018-1036-2</ArticleId><ArticleId IdType="pubmed">30409137</ArticleId><ArticleId IdType="pmc">6225616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, H., Wang, B., Gao, Q., et al.: Comparison between EQ-5D and SF-6D utility in rural residents of Jiangsu Province, China. PLoS ONE 7, e41550 (2012). https://doi.org/10.1371/journal.pone.0041550</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041550</ArticleId><ArticleId IdType="pubmed">22848526</ArticleId><ArticleId IdType="pmc">3407238</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, R.H., Wong, E., Su, Y., et al.: Quantifying the effect of financial burden on health-related quality of life among patients with non-Hodgkin&#x2019;s lymphomas. Cancers (Basel) 12, 3325 (2020). https://doi.org/10.3390/cancers12113325</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12113325</ArticleId><ArticleId IdType="pubmed">33187112</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J.E., Lou, V.W., Jian, H., et al.: Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients. Support Care Cancer 26, 1265&#x2013;1272 (2018). https://doi.org/10.1007/s00520-017-3949-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-017-3949-4</ArticleId><ArticleId IdType="pubmed">29105024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya, S., Berkowitz, A.L.: Primary angiitis of the central nervous system: avoiding misdiagnosis and missed diagnosis of a rare disease. Pract. Neurol. (2016). https://doi.org/10.1136/practneurol-2015-001332</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2015-001332</ArticleId><ArticleId IdType="pubmed">26837371</ArticleId></ArticleIdList></Reference><Reference><Citation>Harutunian, G.M., Beydoun, S.R., Rison, R.A.: Kennedy disease misdiagnosed as polymyositis: a case report. BMC Res. Notes 6, 389 (2013). https://doi.org/10.1186/1756-0500-6-389</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-6-389</ArticleId><ArticleId IdType="pubmed">24073646</ArticleId><ArticleId IdType="pmc">3852050</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparounas, K., Gotsi, A., Syrrou, M., et al.: Kennedy disease: avoiding misdiagnosis. Arch. Neurol. 60, 893&#x2013;894 (2003). https://doi.org/10.1001/archneur.60.6.893</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.6.893</ArticleId><ArticleId IdType="pubmed">12810497</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott Stephen, M.B., Currie, J., Albert Paul, M., et al.: Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma. Chest 141, 616&#x2013;624 (2012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-0948</ArticleId><ArticleId IdType="pubmed">21868466</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto, M., Rinaldi, C.: From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet? Mol. Cell Endocrinol. 465, 113&#x2013;121 (2018)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2017.07.005</ArticleId><ArticleId IdType="pubmed">28688959</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer, J., St&#xf6;llberger, C.: Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease. Mol. Genet. Metab. Rep. 14, 44&#x2013;46 (2018). https://doi.org/10.1016/j.ymgmr.2017.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgmr.2017.11.007</ArticleId><ArticleId IdType="pubmed">29326874</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki, A., Katsuno, M., Suzuki, K., et al.: Brugada syndrome in spinal and bulbar muscular atrophy. Neurology 82, 1813&#x2013;1821 (2014). https://doi.org/10.1212/WNL.0000000000000434</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000434</ArticleId><ArticleId IdType="pubmed">24759840</ArticleId></ArticleIdList></Reference><Reference><Citation>Francini-Pesenti, F., Querin, G., Martini, C., et al.: Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of Italian patients with spinal-bulbar muscular atrophy. Acta Myol. 37, 204&#x2013;209 (2018)</Citation><ArticleIdList><ArticleId IdType="pubmed">30838350</ArticleId><ArticleId IdType="pmc">6390113</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson, A.G., Sundh, D., Johansson, L., et al.: Type 2 diabetes mellitus is associated with better bone microarchitecture but lower bone material strength and poorer physical function in elderly women: a population-based study. J. Bone Miner Res. 32, 1062&#x2013;1071 (2017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3057</ArticleId><ArticleId IdType="pubmed">27943408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonds, D.E., Larson, J.C., Schwartz, A.V., et al.: Risk of fracture in women with type 2 diabetes: the women&#x2019;s health initiative observational study. J. Clin. Endocrinol. Metab. 91, 3404&#x2013;3410 (2006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2006-0614</ArticleId><ArticleId IdType="pubmed">16804043</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin, N., Klein, C., Mandrekar, J., et al.: Natural history of spinal-bulbar muscular atrophy. Neurology 70, 1967&#x2013;1971 (2008). https://doi.org/10.1212/01.wnl.0000312510.49768.eb</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000312510.49768.eb</ArticleId><ArticleId IdType="pubmed">18490617</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen, J.A., Yu, Z., Mo, K., et al.: Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy. Neurobiol Dis. 34, 113&#x2013;120 (2008). https://doi.org/10.1016/j.nbd.2008.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.12.009</ArticleId><ArticleId IdType="pubmed">19211034</ArticleId><ArticleId IdType="pmc">4209964</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, M.J., Asselman, F.-L., Kruitwagen-van Reenen, E.T., et al.: Psychological well-being in adults with spinal muscular atrophy: the contribution of participation and psychological needs. Disabil. Rehabil. 42, 2262&#x2013;2270 (2020). https://doi.org/10.1080/09638288.2018.1555864</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2018.1555864</ArticleId><ArticleId IdType="pubmed">30696284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper, E., Wegrzyn, M., Marx, I., et al.: Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy&#x2019;s disease. Amyotroph. Lateral Scler. Front. Degener. 15, 15&#x2013;20 (2014)</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.837927</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlenbusch, N., L&#xf6;we, B., Depping, M.K.: Perceived burden in dealing with different rare diseases: a qualitative focus group study. BMJ Open 9, e033353 (2019)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-033353</ArticleId><ArticleId IdType="pubmed">31888936</ArticleId><ArticleId IdType="pmc">6937088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bl&#xf6;&#xdf;, S., Klemann, C., Rother, A.-K., et al.: Diagnostic needs for rare diseases and shared prediagnostic phenomena: results of a German-wide expert Delphi survey. PLoS ONE 12, e0172532 (2017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0172532</ArticleId><ArticleId IdType="pubmed">28234950</ArticleId><ArticleId IdType="pmc">5325301</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vgren, R.N., PhD, M., Sejersen, M.D., PhD, T., Kreicbergs, R.N., PhD, U.: Parents&#x2019; experiences and wishes at end of life in children with spinal muscular atrophy types I and II. J. Pediatr. 175, 201&#x2013;205 (2016). https://doi.org/10.1016/j.jpeds.2016.04.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.04.062</ArticleId><ArticleId IdType="pubmed">27241662</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns, T.M., Crowell, J.L., Smith, A.G.: A crisis in US drug pricing: consequences for patients with neuromuscular diseases, physicians and society, part 1. Muscle Nerve 62, 567&#x2013;572 (2020). https://doi.org/10.1002/mus.27015</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27015</ArticleId><ArticleId IdType="pubmed">32725634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers, G.M., Settumba, S.N., Carey, K.A., et al.: Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy. Neurology 95, 1&#x2013;10 (2020). https://doi.org/10.1212/WNL.0000000000009715</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009715</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, R.H., Wong, L., Jin, J., et al.: Health-related quality of life measured using EQ-5D in patients with lymphomas. Supp. Care Cancer (2020). https://doi.org/10.1007/s00520-020-05774-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-020-05774-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam, C.L.K.: Subjective quality of life measures&#x2014;general principles and concepts. In: Preedy, V.R., Watson, R.R. (eds.) Handbook of Disease Burdens and Quality of Life Measures, pp. 381&#x2013;399. Springer, New York (2010). https://doi.org/10.1007/978-0-387-78665-0_21</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-78665-0_21</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrera, P.M., Kantarjian, H.M., Blinder, V.S.: The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J. Clin. 68, 153&#x2013;165 (2018). https://doi.org/10.3322/caac.21443</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21443</ArticleId><ArticleId IdType="pubmed">29338071</ArticleId><ArticleId IdType="pmc">6652174</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischbeck, K.H.: Developing treatment for spinal and bulbar muscular atrophy. Prog. Neurobiol. 99, 257&#x2013;261 (2012). https://doi.org/10.1016/j.pneurobio.2012.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2012.05.012</ArticleId><ArticleId IdType="pubmed">22668795</ArticleId><ArticleId IdType="pmc">3460036</ArticleId></ArticleIdList></Reference><Reference><Citation>He, J., Kang, Q., Hu, J., et al.: China has officially released its first national list of rare diseases. Intractable Rare Dis. Res. 7, 145&#x2013;147 (2018)</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2018.01056</ArticleId><ArticleId IdType="pubmed">29862160</ArticleId><ArticleId IdType="pmc">5982625</ArticleId></ArticleIdList></Reference><Reference><Citation>Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 12, 1061&#x2013;1067 (2003). https://doi.org/10.1002/hec.787</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.787</ArticleId><ArticleId IdType="pubmed">14673814</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazier, J., Roberts, J., Tsuchiya, A., et al.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13, 873&#x2013;884 (2004). https://doi.org/10.1002/hec.866</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.866</ArticleId><ArticleId IdType="pubmed">15362179</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll, L., Benson, G., Lambert, J., et al.: Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United Kingdom. Patient Prefer. Adherence 13, 941&#x2013;957 (2019)</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S202773</ArticleId><ArticleId IdType="pubmed">31354248</ArticleId><ArticleId IdType="pmc">6585419</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, R.H., Dong, D., Luo, N., et al.: Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia. Eur. J. Heal. Econ. 22, 547&#x2013;557 (2021). https://doi.org/10.1007/s10198-021-01273-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-021-01273-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, F., Yue, M., Yang, H., et al.: Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Value Heal. 13, 649&#x2013;656 (2010). https://doi.org/10.1111/j.1524-4733.2010.00728.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2010.00728.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>